title: Moraxella catarrhalis-induced septic arthritis of a prosthetic knee joint in a patient with rheumatoid arthritis treated with anakinra: comment on the article by Schiff et al.
authors.forename: Aggeliki
authors.initials: A
authors.lastname: Leonardou
authors.forename: Sofia
authors.initials: S
authors.lastname: Giali
authors.forename: Dimitris
authors.initials: D
authors.lastname: Daoussis
authors.forename: Vassiliki
authors.initials: V
authors.lastname: Siambi
authors.forename: Haralambos
authors.initials: H
authors.lastname: Gogos
authors.forename: Stamatis-Nick C
authors.initials: SN
authors.lastname: Liossis
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001170:Arthritis, Infectious / Q000209:etiology* / Q000276:immunology; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D053590:Interleukin 1 Receptor Antagonist Protein; D008297:Male; D001936:Moraxella catarrhalis / Q000302:isolation & purification* / Q000472:pathogenicity; D045828:Moraxellaceae Infections / Q000150:complications* / Q000276:immunology; D012795:Sialoglycoproteins / Q000009:adverse effects*
chemical_list: D018501:Antirheumatic Agents; C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D012795:Sialoglycoproteins